Monday’s oil slide briefly lifted airlines. The Qeshm Island strike reversed it.
iPhone 18 Pro demand looks solid. The December guide moves the stock.
With Humana and UnitedHealth pulling out of nearly a million Medicare Advantage plans for 2027, CVS’s Q3...
Orders jumped 96% in Q3, guidance rose, and Trench targets a key grid bottleneck.
The October 30 selloff says the auction premium faded. Can NXP's price make up for it?
When the go-to hedge sells off with equities, investors should ask what they actually hold.
A 49.3 reading below every major forecast puts BHP, RIO, and commodity-linked names in the crosshairs at...
R2 is now Rivian’s top seller, and Q4 looks bigger. Here is why that matters more than...
Skyrizi and Rinvoq now dwarf Humira. Watch Q3 for the cleanest read yet.
TMUS's 34% EPS jump and raised guidance point beyond wireless.
